SPARC-C Study for Large Colon Polyps
The SPARC-C study is looking at how doctors manage large colon polyps (LNPCPs), which are growths in your colon. This study observes patients who are already receiving endoscopic tissue resection (a procedure to remove polyps using a scope) as part of their regular care. Doctors will be looking at how successful these procedures are right after they happen and then again six months later. You might be able to join if you are 18 or older and have been referred for treatment of a large colon polyp. This study is currently unclear on its recruitment status.
- Study design
- This is an observational study aiming to enroll 3500 participants. It is not a randomized study, meaning participants are not assigned to different treatment groups.
- What's involved
- Patients will undergo endoscopic tissue resection as part of their standard care. Data will be collected on your health details, the polyp, the procedure, and your outcomes.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your clinical success will be measured at 6 months after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
At a glance
Conditions
Where it's being run
6 sites across 3 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Technical Success of Endoscopic ProcedureIntra-procedure
Complete removal of all visible polypoid tissue during index procedure.
- Clinical Success of Endoscopic Procedure6 months
Technical success and the avoidance of surgery for large non-pedunculated colorectal polyps (LNPCPs) referred for endoscopic resection, assessed at first surveillance colonoscopy. LNPCPs with features consistent with invasive disease and directly referred for surgery are excluded.